Titan Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch TTNP and buy or sell other stocks, ETFs, and their options commission-free!About TTNP
Titan Pharmaceuticals, Inc. engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura. Its lead product is probuphine, a buprenorphine implant for the maintenance treatment of opioid addiction.
CEOWeei Jye Chay
CEOWeei Jye Chay
Employees—
Employees—
HeadquartersNew York, New York
HeadquartersNew York, New York
Founded1992
Founded1992
Employees—
Employees—
TTNP Key Statistics
Market cap33.52M
Market cap33.52M
Price-Earnings ratio-1.71
Price-Earnings ratio-1.71
Dividend yield—
Dividend yield—
Average volume—
Average volume—
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$5.76
52 Week high$5.76
52 Week low$3.03
52 Week low$3.03
Stock Snapshot
Titan Pharmaceuticals(TTNP) stock is priced at $23.98, giving the company a market capitalization of 33.52M. It carries a P/E multiple of -1.71.
During the trading day, Titan Pharmaceuticals(TTNP) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0.
The stock's 52-week range extends from a low of $3.03 to a high of $5.76.
The stock's 52-week range extends from a low of $3.03 to a high of $5.76.
People also own
Based on the portfolios of people who own TTNP. This list is generated using Robinhood data, and it’s not a recommendation.